OTCMKTS:FZMD

Fuse Medical Stock Forecast, Price & News

$0.09
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.09
Now: $0.09
$0.09
50-Day Range
$0.09
MA: $0.11
$0.15
52-Week Range
$0.00
Now: $0.09
$0.35
VolumeN/A
Average Volume18,916 shs
Market Capitalization$6.74 million
P/E RatioN/A
Dividend YieldN/A
Beta0.87
Fuse Medical, Inc. manufactures and distributes medical devices implants in the United States. The company offers orthopedic implants, including internal and external fixation products; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; full spinal implants for trauma, degenerative disc disease, and deformity indications; and various osteo-biologics, and regenerative and amniotic tissues, which comprise human allografts, substitute bone materials, tendons, and regenerative tissues and fluids. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.
Fuse Medical logo

Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:FZMD
CUSIPN/A
Phone469-862-3030
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$22.90 million
Book Value($0.02) per share

Profitability

Net Income$-3,320,000.00

Miscellaneous

Market Cap$6.74 million
Next Earnings Date5/28/2021 (Estimated)
OptionableNot Optionable

Headlines

How Much Of Velocys plc (LON:VLS) Do Institutions Own?
December 4, 2020 |  finance.yahoo.com
Velocys plc (VLS.L)
October 20, 2020 |  au.finance.yahoo.com
Velocys plc (O7N.F)
October 9, 2020 |  in.finance.yahoo.com
FZMD.PK - Fuse Medical Inc Profile | Reuters
October 3, 2019 |  www.reuters.com
Fuse Medical Reports Second Quarter 2019 Results
August 13, 2019 |  finance.yahoo.com
Fuse Medical Reports First Quarter 2019 Results
May 9, 2019 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.83 out of 5 stars

Medical Sector

1174th out of 2,024 stocks

Medical & Hospital Equipment Industry

4th out of 7 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
$0.09
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FZMD News and Ratings via Email

Sign-up to receive the latest news and ratings for FZMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Fuse Medical (OTCMKTS:FZMD) Frequently Asked Questions

What stocks does MarketBeat like better than Fuse Medical?

Wall Street analysts have given Fuse Medical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fuse Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Fuse Medical?

Fuse Medical saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 300 shares, an increase of 200.0% from the March 15th total of 100 shares. Based on an average daily trading volume, of 20,700 shares, the days-to-cover ratio is presently 0.0 days.
View Fuse Medical's Short Interest
.

When is Fuse Medical's next earnings date?

Fuse Medical is scheduled to release its next quarterly earnings announcement on Friday, May 28th 2021.
View our earnings forecast for Fuse Medical
.

How were Fuse Medical's earnings last quarter?

Fuse Medical, Inc. (OTCMKTS:FZMD) announced its quarterly earnings data on Monday, August, 10th. The company reported ($0.01) earnings per share for the quarter. The company earned $4.01 million during the quarter.
View Fuse Medical's earnings history
.

How has Fuse Medical's stock been impacted by COVID-19 (Coronavirus)?

Fuse Medical's stock was trading at $0.55 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FZMD stock has decreased by 83.2% and is now trading at $0.0922.
View which stocks have been most impacted by COVID-19
.

Who are Fuse Medical's key executives?

Fuse Medical's management team includes the following people:
  • Mr. Mark W. Brooks, Chairman & Pres (Age 55, Pay $1.31M)
  • Mr. Christopher C. Reeg, CEO, Sec. & Director (Age 57, Pay $302.08k)
  • Mr. William E. McLaughlin III, Sr. VP, CFO, Treasurer & Director (Age 57, Pay $200k)

Who are some of Fuse Medical's key competitors?

What other stocks do shareholders of Fuse Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fuse Medical investors own include Bank of America (BAC), Huntington Bancshares (HBAN) and Fiat Chrysler Automobiles (FCAU).

What is Fuse Medical's stock symbol?

Fuse Medical trades on the OTCMKTS under the ticker symbol "FZMD."

How do I buy shares of Fuse Medical?

Shares of FZMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fuse Medical's stock price today?

One share of FZMD stock can currently be purchased for approximately $0.09.

How much money does Fuse Medical make?

Fuse Medical has a market capitalization of $6.74 million and generates $22.90 million in revenue each year.

What is Fuse Medical's official website?

The official website for Fuse Medical is www.fusemedical.com.

Where are Fuse Medical's headquarters?

Fuse Medical is headquartered at 1565 N. CENTRAL EXPRESSWAY SUITE 220, RICHARDSON TX, 75080.

How can I contact Fuse Medical?

Fuse Medical's mailing address is 1565 N. CENTRAL EXPRESSWAY SUITE 220, RICHARDSON TX, 75080. The company can be reached via phone at 469-862-3030.


This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.